This study was conducted to assess the safety and tolerability of Abatacept combined with
Methotrexate in participants with active rheumatoid arthritis (RA). The secondary objectives
were to assess efficacy, pharmacodynamic marker activity, and immunogenicity of Abatacept
combined with Methotrexate.